Brokerages Set ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Price Target at $24.00
Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) have earned a consensus rating of “Buy” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average 1-year target […]
More Stories
PIMCO 15+ Year U.S. TIPS Index Exchange-Traded Fund (NYSEARCA:LTPZ) Sees Large Volume Increase – Time to Buy?
Shares of PIMCO 15+ Year U.S. TIPS Index Exchange-Traded Fund (NYSEARCA:LTPZ – Get Free Report) saw unusually-high trading volume on...
89bio (NASDAQ:ETNB) Shares Down 8.4% – Should You Sell?
89bio, Inc. (NASDAQ:ETNB – Get Free Report) fell 8.4% during trading on Tuesday . The stock traded as low as...
Pan Global Resources (CVE:PGZ) Hits New 52-Week Low – Time to Sell?
Pan Global Resources Inc. (CVE:PGZ – Get Free Report) shares hit a new 52-week low during trading on Tuesday ....
Lavoro (NASDAQ:LVRO) Trading 6.9% Higher – Still a Buy?
Shares of Lavoro Limited (NASDAQ:LVRO – Get Free Report) shot up 6.9% during mid-day trading on Tuesday . The company...
Pampa Energía (NYSE:PAM) Hits New 12-Month High – Should You Buy?
Pampa Energía S.A. (NYSE:PAM – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock...
Vertiv Holdings Co (NYSE: VRT) Enters Into Ninth Amendment to Revolving Credit Agreement
Vertiv Holdings Co, a Delaware corporation, announced on November 12, 2024, that it has entered into Amendment No. 9 to...